Source
Rare Disease Advisor
Despite advances in noninvasive diagnostic techniques, patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) in the Czech Republic still experience a significant diagnostic delay, according to a recently published study in the Orphanet Journal of Rare Diseases.
News Url